Wright Medical (WMGI) Updates FY13 Earnings Guidance
Wright Medical (WMGI) updated its FY13 earnings guidance on Thursday. The company provided earnings per share guidance of $0.00-0.06 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.09. The company issued revenue guidance of $485-495 million, compared to the consensus revenue estimate of $484.26 million.
Wright Medical (WMGI) traded down 0.70% on Thursday, hitting $21.28. Wright Medical (WMGI) has a 1-year low of $16.05 and a 1-year high of $22.59. The stock’s 50-day moving average is currently $21.5. The company has a market cap of $827.9 million and a price-to-earnings ratio of 765.36.
Wright Medical last announced its earnings results on Thursday, February 21st. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.03. The company had revenue of $123.50 million for the quarter, compared to the consensus estimate of $120.93 million. During the same quarter in the previous year, the company posted $0.17 earnings per share. The company’s revenue for the quarter was down 2.7% on a year-over-year basis. Wright Medical has set its FY13 guidance at $0.00-0.06 EPS. On average, analysts predict that Wright Medical (WMGI) will post $0.21 earnings per share for the current fiscal year.
Wright Medical Group, Inc. (Wright) through its subsidiary Wright Medical Technology Inc, and other operating subsidiaries is an orthopaedic medical device company engaged in the design, manufacture and marketing of devices and biologic products for extremity, hip, and knee repair and reconstruction.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.